| Vaccine protection against Zika virus from Brazil RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ... Nature 536 (7617), 474-478, 2016 | 596 | 2016 |
| Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys DH Barouch, J Liu, H Li, LF Maxfield, P Abbink, DM Lynch, MJ Iampietro, ... Nature 482 (7383), 89-93, 2012 | 521 | 2012 |
| First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001) LR Baden, SR Walsh, MS Seaman, RP Tucker, KH Krause, A Patel, ... The Journal of infectious diseases 207 (2), 240-247, 2013 | 185 | 2013 |
| Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection RR Bradley, DM Lynch, MJ Iampietro, EN Borducchi, DH Barouch Journal of virology 86 (1), 625-629, 2012 | 166 | 2012 |
| Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001) DH Barouch, J Liu, L Peter, P Abbink, MJ Iampietro, A Cheung, G Alter, ... The Journal of infectious diseases 207 (2), 248-256, 2013 | 138 | 2013 |
| Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys JE Teigler, MJ Iampietro, DH Barouch Journal of virology 86 (18), 9590-9598, 2012 | 124 | 2012 |
| Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions RR Bradley, LF Maxfield, DM Lynch, MJ Iampietro, EN Borducchi, ... Journal of virology 86 (2), 1267-1272, 2012 | 97 | 2012 |
| Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors P Penaloza-MacMaster, NM Provine, J Ra, EN Borducchi, A McNally, ... Journal of virology 87 (3), 1373-1384, 2013 | 86 | 2013 |
| Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors P Abbink, LF Maxfield, D Ng'ang'a, EN Borducchi, MJ Iampietro, ... Journal of virology 89 (3), 1512-1522, 2015 | 60 | 2015 |
| First-in-human randomized, controlled trial of mosaic HIV-1 immunogens delivered via a modified vaccinia Ankara vector LR Baden, SR Walsh, MS Seaman, YZ Cohen, JA Johnson, JH Licona, ... The Journal of Infectious Diseases 218 (4), 633-644, 2018 | 35 | 2018 |
| Adenovirus vector-based vaccines confer maternal-fetal protection against Zika virus challenge in pregnant IFN-αβR−/− mice RA Larocca, EA Mendes, P Abbink, RL Peterson, AJ Martinot, ... Cell host & microbe 26 (5), 591-600. e4, 2019 | 28 | 2019 |
| Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function RA Larocca, NM Provine, M Aid, MJ Iampietro, EN Borducchi, ... Science immunology 1 (5), eaaf7643, 2016 | 20 | 2016 |
| Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens PP MacMaster, JL Shields, QA Alayo, C Cabral, J Jimenez, J Mondesir, ... Vaccine 35 (1), 1-9, 2017 | 18 | 2017 |
| Accelerated heterologous adenovirus prime-boost SIV vaccine in neonatal rhesus monkeys J Liu, H Li, MJ Iampietro, DH Barouch Journal of virology 86 (15), 7829-7835, 2012 | 15 | 2012 |
| Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy A Badamchi-Zadeh, KD Moynihan, RA Larocca, M Aid, NM Provine, ... The Journal of Immunology 201 (9), 2744-2752, 2018 | 14 | 2018 |
| Immunogenicity and cross-reactivity of rhesus adenoviral vectors MJ Iampietro, RA Larocca, NM Provine, P Abbink, ZH Kang, CA Bricault, ... Journal of Virology 92 (11), 10.1128/jvi. 00159-18, 2018 | 11 | 2018 |
| Recombinant adenoviruses and uses thereof DH Barouch, P Abbink, MJ Iampietro, MJE Havenga US Patent 11,773,142, 2023 | 1 | 2023 |
| Adenovirus 5 vaccination elicits IL-27, which impairs CD4 and CD8 T cell functionality (VAC12P. 1113) R Larocca, N Provine, M Iampietro, E Borducchi, P Penaloza-MacMaster, ... The Journal of Immunology 194 (1_Supplement), 213.4-213.4, 2015 | 1 | 2015 |
| Immunogenicity and Cross-reactivity of Human and Rhesus Adenoviral Vectors MJ Iampietro Harvard University, 2019 | | 2019 |
| Adenovirus Serotype 5 Vectors Trigger IL-27-Dependent Inhibitory CD4+ T Cell Responses RA Larocca, NM Provine, MJ Iampietro, EN Borducchi, ... The Journal of Immunology 196 (1_Supplement), 196.10-196.10, 2016 | | 2016 |
